DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Rugo HS, Tredan O, Ro J et al.
Results from the phase 2 trial of ridaforolimus, dalotuzumab, and exemestane compared to ridaforolimus and exemestane in advanced breast cancer. San Antonio Breast Cancer Symposium 2014; PD5-1.
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.